Heptares initiates expansion plan
15 May 2009
Sukaina Virji
Please Login to read the full article.
15 May 2009
Sukaina Virji
sukaina.virji@informa.com
Heptares Therapeutics, the UK biotechnology company that managed to buck the trend and raise £21 million in a series A financing round earlier this year led by Clarus Ventures, has begun spending the money.
The company has relocated from London – near the Medical Research Council...
Please Login to read the full article.
RELATED CONTENT
NEWS
- AstraZeneca and Heptares coupled in GPCR deal worth more than $188 million
- Heptares grants Shire option on lead discovery programme
- 'Methodical' Blend Therapeutics shuns large A round, to build drug combinations company
- Weaker private equity in India for 2012, portfolios turning 'a la carte'
FEATURES
Other Informa Features
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
